Podcasts about Breast cancer

In this revealing conversation, Grace Helbig opens up about her early days of YouTube stardom, to the burnout that followed, and facing breast cancer head-on. She shares behind-the-scenes stories of navigating the chaos of internet fame, the toll it took on her mental health, and how stepping away gave her the clarity to return on her own terms. Grace dives deep into the emotional and psychological impact of living life online, the loss of community in the creator space, and how her diagnosis reshaped her priorities. Now, with a renewed sense of purpose, she's transforming pain into art through her new live comedy show, bringing humor and honesty to life's hardest moments. Whether you're a longtime fan or discovering Grace for the first time, this episode is an inspiring, unfiltered reminder that it's never too late to reinvent yourself. My new book is available for pre-order! Why Do I Keep Doing This? → https://geni.us/XoyLSQ If you've ever felt stuck, this book is for you. I'd be so grateful for your support. More Grace: https://www.youtube.com/@itsgrace/videos This Might Get Weird (podcast) https://www.youtube.com/channel/UC6qM1-K69UGys_BnilnWZ7w More Kati: https://www.youtube.com/@Katimorton MY BOOKS Traumatized https://geni.us/Bfak0j Are u ok? https://geni.us/sva4iUY Ask Kati Anything ep. 275 | Your mental health podcast, with Kati Morton, LMFT I've teamed up with Babbel to give you 55% off your subscription—but only for listeners—at Babbel.com/KATI ONLINE THERAPY (enjoy 10% off your first month) While I do not currently offer online therapy, BetterHelp can connect you with a licensed, online therapist: https://betterhelp.com/kati PARTNERSHIPS Nick Freeman | nick@biglittlemedia.co Learn more about your ad choices. Visit megaphone.fm/adchoices

It's true... this was not Tess' hot girl summer... in fact...it was quite the opposite. There was a reason Tess' best friend nick named her solo cup...tune in to this week's episode to find out why.And dont worry... not only does Tess give a full life update and what you've missed the past 4 months, she also goes into things she is loving: The Summer I Turned Pretty season 3 AND the announcement of Taylor Swift's new album. Ahhhhhh!!Contact More Or Less With TessInstagram: @moreorlesswithtesspodcastEmail us at moreorlesswithtess@gmail.comLink to Website: https://moreorlesswithtess.buzzsprout.comThanks for listening!

Behind the Knife's General Surgery Oral Board Review Course includes 123 Audio Scenarios + 10 Interactive Video Scenarios + 97 Operative Descriptions that cover all SCORE topic. Each scenario includes two parts. The first part is a perfectly executed oral board scenario that mimics the real thing. Scenarios are 5 to 7 minutes long and include a variety of tactics and styles. If you are able to achieve this level of performance in your preparation you are sure to pass the oral exam with flying colors. The second part introduces high-yield commentary to each scenario. This commentary includes tips and tricks to help you dominate the most challenging scenarios in addition to practical, easy-to-understand teaching that covers the most confusing topics we face as general surgeons. We are confident you will find this unique, dual format approach a highly effective way to prepare for the test. All of our premium courses are available via our website and apps (iOS and Android).  Users can take notes, pin chapters and download content for offline viewing.  Learn more about the General Surgery Oral Board Review Course at https://app.behindtheknife.org/premium/general-surgery-oral-board-review **Institutional Discounts Available - Please email hello@behindtheknife.org to learn more.** Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

About the Guest(s): Dr. Kristin Hieshetter is a prominent expert in the field of functional health, known for her impassioned work in spreading well-researched health information through her platform, Functional Health Radio. With a keen focus on the intersection of lifestyle choices and health outcomes, Dr. Hieshetter draws on extensive research to inform her discussions on critical health topics, including alcohol consumption and its links to cancer. She has garnered appreciation for her analytical approach and commitment to empowering listeners to make informed health decisions. Episode Summary: Join Dr. Kristin Hieshetter as she delves into the critical connection between alcohol consumption and breast cancer on this episode of Functional Health Radio. As alcohol use remains prevalent, understanding its health implications becomes crucial, especially in light of emerging research. Dr. Kristin examines the cultural shifts in alcohol consumption and the heightened awareness about its potential risks, leading into an in-depth discussion based on recent medical findings. In this informative episode, Dr. Kristin highlights the sobering reality illustrated by recent studies, showcasing the increased risk of breast cancer associated with alcohol consumption. From alcohol's biological impact on estrogen levels to its epidemiological connection to various cancers, listeners will gain a comprehensive understanding of the inherent health risks. Dr. Kristin also provides practical advice on reducing these risks, emphasizing mindful consumption and advocating for better dietary and lifestyle choices to mitigate cancer risks. Key Takeaways: Alcohol is widely consumed but poses significant health risks, including increased cancer risk, particularly breast cancer. Studies reveal that every 10-gram increase in alcohol consumption raises breast cancer risk significantly. Alcohol contributes to numerous cancer types, raising estrogen levels, which can exacerbate cancer risk, especially in post-menopausal women. Reducing alcohol intake can significantly lower cancer risk, encouraging more mindful drinking habits. Mocktails, like a raspberry basil concoction, provide healthy, antioxidant-rich alternatives to alcohol. Notable Quotes: "People are just using [alcohol] to medicate, right? Like, well, screw it. The virus is still here, and it's snowing again. I'm gonna have myself a beverage." "Alcohol causes three out of four of those genetic mutations. Scary, right?" "If there's anything you can do to prevent from ever needing cancer or chemotherapy, I want to be in your corner helping coach you through that process." "Be safe, everybody. Okay? So these different patterns of alcohol drinking may have different effects on breast cancer." "One beverage a day raises your risk 200%. Say it again. Have a beverage on a holiday. Have a beverage once a month." Resources: PubMed - Source of numerous studies including data on alcohol and cancer. National Institute on Alcohol Abuse and Alcoholism - Statistics on alcohol use disorders. Pharmacological Reports - Source for the discussed article on alcohol and breast cancer. Women's Health Initiative Observational Study - Study investigating alcohol and cancer risk. Functional Health Mastery Group For a deeper dive into the compelling research behind these findings and to gather more actionable insights on improving health through informed lifestyle choices, tune in to this enlightening episode. Don't miss more expert insights and informative discussions on Functional Health Radio with Dr. Kristin Hieshetter.

BUFFALO, NY - August 13, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on July 29, 2025, titled “PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion.” In this study, led by first author Jassy Mary S. Lazarte and corresponding author Nazarius S. Lamango from Florida A&M University College of Pharmacy and Pharmaceutical Sciences, researchers investigated a new class of compounds called polyisoprenylated cysteinyl amide inhibitors (PCAIs) as a potential treatment for aromatase inhibitor (AI) therapy resistant breast cancer. Aromatase inhibitors are a common treatment for estrogen receptor-positive (ER+) breast cancer, but many patients eventually develop resistance, leaving fewer therapeutic options. The study focused on a PCAI compound called NSL-YHJ-2-27, which was tested in long-term letrozole-treated breast cancer cells (LTLT-Ca), an experimental model of AI therapy resistance. NSL-YHJ-2-27 activated two major signaling pathways, MAPK and PI3K/AKT. Although these pathways typically support cancer cell survival, their overstimulation by PCAIs led to increased oxidative stress, damaging the cells and inducing cell death by apoptosis. The compound also reduced levels of RAC1 and CDC42, proteins involved in maintaining cell shape and movement. These alterations resulted in cytoskeletal disruption and reduced structural integrity, making the cancer cells more vulnerable and less capable of spreading. Importantly, the effects of NSL-YHJ-2-27 persisted after the compound was removed, suggesting long-term control over AI resistant cancer cells may be possible. “PCAIs inhibited cell proliferation and colony formation by 95% and 74%, respectively, increased active caspase 7 and BAX 1.5-fold and 56%, respectively. NSL-YHJ-2-27 (10 μM) induced LTLT-Ca spheroid degeneration by 61%.” As a new class of targeted molecules, PCAIs represent an innovative approach distinct from traditional endocrine therapies. Their ability to affect multiple cellular mechanisms simultaneously makes them promising candidates for future drug development. Overall, this study presents a promising new approach for treating AI therapy-resistant breast cancer. By targeting cellular pathways that support survival and mobility, PCAIs like NSL-YHJ-2-27 could provide a novel strategy to manage advanced or resistant forms of the disease. Further research, including in vivo studies and clinical trials, will be essential to confirm these findings and evaluate their therapeutic potential. DOI - https://doi.org/10.18632/oncotarget.28759 Correspondence to - Nazarius S. Lamango - nazarius.lamango@famu.edu Video short - https://www.youtube.com/watch?v=8xQEilloO9Q Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28759 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, PCAIs, ROS, MAPK, PI3K/AKT, LTLT-Ca cells To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Orthopedic Surgeon, author and advocate Dr. Vonda Wright joins Gabby to discuss her new book Unbreakable, which speaks about the tools that can be used to reframe the way women acknowledge and address the aging process. From everyday tips to daily supplements and routine fit tips, this insightful conversation provides not only a new perspective on aging but a blueprint for tangible improvement. Beyond the concept of aging, Dr. Vonda Wright explores the concepts of vitality and strength, elements that Dr. Wright admits often get overlooked in the discussion around women and aging. In short, this episode celebrates the wisdom that comes with aging while spelling out steps women can take today to protect their health, strength and futures. Don't miss this impactful episode of The Gabby Reece Show.  Timeline - My friends at Timeline are offering 20% off, just for my listeners. Head to timeline.com/gabby to get started. OneSkin - For a limited time, you can try OneSkin with 15% off using code REECE at oneskin.co Vionic - Use the code GABBY at checkout for 15% off your entire order at www.vionicshoes.com when you log into your account. One-time use only. Laird Superfood - High-quality ingredients paired with incredible taste. Use the code GABBY20 for 20% off your purchase at lairdsuperfood.com For more on Gabby Instagram @GabbyReece: https://www.instagram.com/gabbyreece/ TikTok @GabbyReeceOfficial https://www.tiktok.com/@gabbyreeceofficial The Gabby Reece Show Podcast on YouTube: https://www.youtube.com/@GabbyReece  The Gabby Reece Show podcast is Produced by Rainbow Creative (https://www.rainbowcreative.co/)  Connect with Our Guest Dr. Vonda Wright's Website www.drvondawright.com  Follow Dr. Vonda Wright on Instagram  https://www.instagram.com/drvondawright/  Unbreakable: A Woman's Guide to Aging with Power by Dr. Vonda Wright https://a.co/d/0lxQsoA Fitness After 40: Your Strong Body at 40, 50, 60 and Beyond by Dr. Vonda Wright and Ruth Winter https://a.co/d/chL97kR  Estrogen Matters: Why Taking Hormones in Menopause Can Improve and Lengthen Women's Lives - Without Raising the Risk of Breast Cancer by Avrum Bluming and Carol Tavris  https://a.co/d/bgYMEVj  00:00 - The Narrative of Longevity vs. Anti-Aging 04:16 - The Power of a Single Image 08:58 - The Psychological Aspect of Aging 20:48 - The Problem with the Current Narrative about Longevity 28:44 - The Reality of Chronic Illnesses 39:10 - The Unforeseen Dangers of Osteopenia 58:00 - The Catalyst for Writing "Unbreakable" 01:13:30 - The Key to Being Unbreakable Learn more about your ad choices. Visit megaphone.fm/adchoices

Life changes in a split second when you hear the words, “you have breast cancer.” Shawna Bramel and Marian Santos know this personally. Shawna was diagnosed after having her first child, completely upending her family's plans for more children. Marian was diagnosed at a time when she should have been thinking about her future, planning a family and focusing on preserving her reproductive health. Both ladies struggled mentally, emotionally and physically with their diagnoses and are joining us today to share more.

In this eye-opening episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Jessica Peatross for a deeply personal conversation about health, healing, and taking back control of your body and choices.Dr. Peatross shares her journey through years of professional and personal challenges—from nervous system dysregulation and inflammation to reclaiming her health through mindfulness, targeted nutrition, and hormone balance. Together, they explore why medical sovereignty and informed consent are essential, how environmental toxins quietly erode health, and why medicine's future must be built on patient empowerment instead of one-size-fits-all care.This episode dives into the root causes of chronic illness, the overlooked role of detoxification, and mindset shifts that accelerate healing. From hormone therapy done right to personalized protocols honoring your genetics and history, Dr. Peatross offers hard-earned wisdom and practical steps for lasting wellness.In This Episode, You Will Learn:How Dr. Peatross overcame years of health strugglesWhy calming the nervous system is the first step to healingThe role of targeted nutrition and micronutrientsHow reprogramming your mind supports recoveryWhy medical sovereignty matters for informed decisionsThe link between toxins, inflammation, and hormonesHow individualized detox prevents setbacksWhy hormone balance is key to wellnessThe value of curiosity over conformity in medicine

Full article: Associations of Breast Cancer Method of Detection With Tumor Characteristics, Treatments, and Overall Survival: A Propensity-Score Matched Analysis Research into the method of breast cancer detection can help inform screening guidelines. Osvaldo Berlina, MD, discusses the AJR article by Chen et al. that uses a propensity-score matched analysis to understand associations of method of detection with survival outcomes.

How often have you said this about your post-treatment diet, “I was doing so well, and then everything fell apart.”? If you've said it even once, this episode is for you. Today I'm talking about the exhausting pattern so many hormone receptor-positive breast cancer survivors fall into: eating super ‘clean,' then slipping, then swinging back to strict rules out of fear, guilt, or shame. This isn't a willpower issue, it's a trauma-driven response to food and it's incredibly common after hormone receptor-positive breast cancer. If you're tired of starting over, feeling stuck, or believing the problem is you, join me, because I'm sharing a secret. . .there is another way._______________________________Click here to apply to my Peaceful Plate program! Get my FREE guide The Five Foods Survivors Should Eat; click here!Follow me on Instagram @hormone.breastcancer.dietitian

Dr. Hope Rugo and Dr. Kamaria Lee discuss the prevalence of financial toxicity in cancer care in the United States and globally, focusing on breast cancer, and highlight key interventions to mitigate financial hardship. TRANSCRIPT  Dr. Hope Rugo: Hello, and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I'm your host, Dr. Hope Rugo. I'm the director of the Women's Cancer Program and division chief of breast medical oncology at the City of Hope Cancer Center, and I'm also the editor-in-chief of the Educational Book. Rising healthcare costs are causing financial distress for patients and their families across the globe. Patients with cancer report financial toxicity as a major impediment to their quality of life, and its association with worse outcomes is well documented. Today, we'll be discussing how patients with breast cancer are uniquely at risk for financial toxicity. Joining me for this discussion is Dr. Kamaria Lee, a fourth-year radiation oncology resident and health equity researcher at MD Anderson Cancer Center and a co-author of the recently published article titled, "Financial Toxicity in Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?" Our full disclosures are available in the transcript of this episode.  Dr. Lee, it's great to have you on this podcast. Dr. Kamaria Lee: Hey, Dr. Rugo. Thank you so much for having me. I'm excited to be here today. I also would like to recognize my co-authors, Dr. Alexandru Eniu, Dr. Christopher Booth, Molly MacDonald, and Dr. Fumiko Chino, who worked on this book chapter with me and did a fantastic presentation on the topic at ASCO this past year. Dr. Hope Rugo: Thanks very much. We'll now just jump into the questions. We know that rising medical costs contribute to a growing financial burden on patients, which has [GC1]  [JG2]  been documented to contribute to lower quality-of-life, compromised clinical care, and worse health outcomes. How are patients with breast cancer uniquely at risk for financial toxicity? How does the problem vary within the breast cancer population in terms of age, racial and ethnic groups, and those who have metastatic disease? Dr. Kamaria Lee: Breast cancer patients are uniquely at risk of financial toxicity for several reasons. Three key reasons are that breast cancer often requires multimodal treatment. So this means patients are receiving surgery, many receive systemic therapies, including hormonal therapies, as well as radiation. And so this requires care coordination and multiple visits that can increase costs. Secondly, another key reason that patients with breast cancer are uniquely at risk for financial toxicity is that there's often a long survivorship period that includes long-term care for toxicities and continued follow-ups, and patients might also be involved in activities regarding advocacy, but also physical therapy and mental health appointments during their prolonged survivorship, which can also add costs. And a third key reason that patients with breast cancer are uniquely at risk for financial toxicity is that the patient population is primarily women. And we know that women are more likely to have increased caregiver responsibilities while also potentially working and managing their treatments, and so this is another contributor. Within the breast cancer population, those who are younger and those who are from marginalized racial/ethnic groups and those with metastatic disease have been shown to be at an increased risk. Those who are younger may be more likely to need childcare during treatment if they have kids, or they're more likely to be employed and not yet retired, which can be disrupted while receiving treatment. And those who are racial/ethnic minorities may have increased financial toxicity due to reasons that exist even after controlling for socioeconomic factors. And some of these reasons have been shown to be increased risk of job or income loss or transportation barriers during treatment. And lastly, for those with metastatic breast cancer, there can be ongoing financial distress due to the long-term care that is needed for treatment, and this can include parking, transportation, and medications while managing their metastatic disease. Dr. Hope Rugo: I think it is really important to understand these issues as you just outlined. There has been a lot of focus on financial toxicity research in recent years, and that has led to novel approaches in screening for financial hardship. Can you tell us about the new screening tools and interventions and how you can easily apply that to clinical practice, keeping in mind that people aren't at MD Anderson with a bunch of support and information on this but are in clinical practice and seeing many, many patients a day with lots of different cancers? Dr. Kamaria Lee: You're exactly right that there is incredible nuance needed in understanding how to best screen for financial hardship in different types of practices. There are multiple financial toxicity tools. The most commonly used tool is the Comprehensive Score for Financial Toxicity, also known as the COST tool. In its full form, it's an 11-item survey. There's also a summary question as well. And these questions look at objective and subjective financial burden, and it uses a five-point Likert scale. For example, one question on the full form is, "I know that I have enough money in savings, retirement, or assets to cover the cost of my treatment," and then patients are able to respond "not at all" to "very much" with a threshold score for financial toxicity risk. Of course, as you noted, one critique of having an 11-item survey is that there's limited time in patient encounters with their providers. And so recently, Thom et al validated an abbreviated two-question version of the COST tool. This validation was done in an urban comprehensive cancer center, and it was found to have a high predictive value to the full measure. We note which two questions are specifically pulled from the full measure within the book chapter. And this is one way that it can be easier for clinicians who are in a busier setting to still screen for financial toxicity with fewer questions. I also do recommend that clinicians who know their clinic's workflow the best, work with their team of nurses, financial navigators, and others to best integrate the tool into their workflow. For some, this may mean sending the two-item survey as a portal message so that patients can answer it before consults. Other times, it could mean having it on the tablet that can be done in the clinic waiting room. And so there are different ways that screening can be done, even in a busy setting, and acknowledging that different practices have different amounts of resources and time. Dr. Hope Rugo: And where would people access that easily? I recognize that that information is in your chapter, or your article that's on PubMed that will be linked to this podcast, but it is nice to just know where people could easily access that online. Dr. Kamaria Lee: Yes, and so you should be able to Google ‘the COST measure', and then there is a website that also has the forms as well. So it's also beyond the book chapter, Googling ‘the COST measure', and then online they would be able to find access to the form. Dr. Hope Rugo: And how often would you do that screening? Dr. Kamaria Lee: So, I think it's definitely important that we are as proactive as possible. And so initially, I recommend that the screening happens at the time of diagnosis, and so if it's done through the portal, it can be sent before the initial consult, or again, however, is best in the workflow. So at the time of diagnosis and then at regular intervals, so throughout the treatment process, but then also into the follow-up period as well to best understand if there's still a financial burden even after the treatments have been completed. Dr. Hope Rugo: I wonder if in the metastatic setting, you could do it at the change of treatment, you know, a month after somebody's changed treatment, because people may not be as aware of the financial constraints when they first get prescribed a drug. It's more when you hear back from how much it's going to cost. And leading into that, I think it's, what do you do with this? So, you know, this cost conversation is really important. You're going to be talking to the patient about the cost considerations when you, for example, see that there are financial issues, you're prescribing treatments. How do we implement impactful structured cost conversations with our breast cancer patients, help identify financial issues, and intervene? How do we intervene? I mean, as physicians often we aren't really all that aware, or providers, of how to address the cost. Dr. Kamaria Lee: Yes, I agree fully that another key time when to screen for financial toxicity is at that transition between treatments to best understand where they're at based off of what they've received previously for care, and then to anticipate needs when changing regimens, such as like you said in the metastatic setting. As we're collecting this information, you're right, we screen, we get this information, and what do we do? I do agree that there is a lack of knowledge among us clinicians of how do we manage this information. What is insurance? How do we manage insurance and help patients with insurance concerns? How do we help them navigate out-of-pocket costs or even the indirect costs of transportation? Those are a lot of things that are not covered in-depth in traditional medical training. And so it can be overwhelming for a lot of clinicians, not only due to time limitations in clinic, but also just having those conversations within their visit. And so what I would say, a key thing to note, is that this is another area for multidisciplinary care. So just as we're treating patients in a multidisciplinary way within oncology as we work with our medical oncology, surgical colleagues across the board, it's knowing that this is another area for multidisciplinary care. So the team members include all of the different oncologists, but it also includes team members such as financial counselors and navigators and social workers and even understanding nonprofit partners who we have who have money that can be set aside to help reduce costs for certain different aspects of treatment. Another thing I will note is that most patients with breast cancer often say they do want to have these conversations still with their clinicians. So they do still see a clinician as someone that can weigh in on the costs of their treatment or can weigh in on this other aspect of their care, even if it's not the actual medication or the radiation. And so patients do desire to hear from their clinicians about this topic, and so I think another way to make it feel less overwhelming for clinicians like ourselves is to know that even small conversations are helpful and then being knowledgeable about within your institution or, like I said, outside of it with nonprofits, being aware of who can I refer this patient to for continued follow-up and for more detailed information and resources. Dr. Hope Rugo: Are those the successful interventions? It's really referring to financial navigators? How do people identify? You know, in an academic center, we often will sort of punt this to social workers or our nurse navigators. What about in the community? What's a successful intervention example of mitigating financial toxicity? Dr. Kamaria Lee: I agree completely that the context at which people are practicing is important to note. So as you alluded to, in some bigger systems, we do have financial navigators and this has been seen to be successful in providing applications and assisting with applications for things such as pharmaceutical assistance, insurance applications, discount opportunities.  Another successful intervention are financial toxicity tumor boards, which I acknowledge might not be able to exist everywhere. But where this is possible, multidisciplinary tumor boards that include both doctors and nurses and social workers and any other members of the care team have been able to effectively decrease patients' personal spending on care costs and decrease co-pays through having a dedicated time to discuss concerns as they arise or even proactively. Otherwise, I think in the community, there are other interventions in regards to understanding different aspects of government programs that might be available for patients that are not, you know, limited to an institution, but that are more nationally available, and then again, also having the nonprofit, you know, partnerships to see other resources that patients can have access to.  And then I would also say that the indirect costs are a significant burden for many patients. So by that, I mean even parking costs, transportation, childcare. And so even though those aren't interventions necessarily with someone who is a financial navigator, I would recommend that even if it's a community practice, they discuss ways that they can help offset those indirect costs with patients with parking or if there are ways to help offset transportation costs or at least educate patients on other centers that may be closer to them or they can still receive wonderful care, and then also making sure that patients are able to even have appointments scheduled in ways that are easier for them financially.  So even if someone's receiving care out in the community where there's not a financial navigator, as clinicians or our scheduling teams, sometimes there are options to make sure if a patient wants, visits are more so on one day than throughout the week or many hours apart that can really cause loss of income due to missed work. And so there are also kind of more nuanced interventions that can happen even without a financial navigation system in place. Dr. Hope Rugo: I think that those are really good points and it is interesting when you think about financial toxicity. I mean, we worry a lot when patients can't take the drugs because they can't afford them, but there are obviously many other non-treatment, direct treatment-related issues that come up like the parking, childcare, tolls, you know, having a working car, all those kinds of things, and the unexpected things like school is out or something like that that really play a big role where they don't have alternatives. And I think that if we think about just drug costs, I think those are a big issue in the global setting. And your article did address financial toxicity in the global setting. International financial toxicity rates range from 25% of patients with breast cancer in high-income countries to nearly 80% in low- and middle-income countries or LMICs. You had cited a recent meta-analysis of the global burnout from cancer, and that article found that over half of patients faced catastrophic health expenditures. And of course, I travel internationally and have a lot of colleagues who are working in oncology in many countries, and it is really often kind of shocking from our perspective to see what people can get coverage for and how much they have to pay out-of-pocket and how much that changes, that causes a lot of disparity in access to healthcare options, even those that improve survival. Can you comment on the global impact of this problem? Dr. Kamaria Lee: I am glad that you brought this up for discussion as well. Financial toxicity is something that is a significant global issue. As you mentioned, as high as 80% of patients with breast cancer in low- and middle-income countries have had significant financial toxicity. And it's particularly notable that even when looking at breast cancer compared to other malignancies around the world, the burden appears to be worse. This has been seen even in countries with free universal healthcare. One example is Sri Lanka, where they saw high financial toxicity for their patients with breast cancer, even with this free universal healthcare. But there were also those travel costs and just additional out-of-hospital tests that were not covered. Also, literature in low- and middle-income countries shows that patients might also be borrowing money from their social networks, so from their family and their friends, to help cover their treatment costs, and in some cases, people are making daily food compromises to help offset the cost of their care. So there is a really large burden of financial toxicity generally for cancer globally, but also specifically in breast cancer, it warrants specific discussion. In the meta-analysis that you mentioned, they identified key risk factors of financial toxicity globally that included people who had a larger family size, a lower income, a lack of insurance, longer disease duration, so again, the accumulation of visits and costs and co-pay over time, and those who had multiple treatments. And so in the global setting, there is this significant burden, but then I will also note that there is a lack of literature in low-income countries on financial toxicity. So where we suspect that there is a higher burden and where we need to better understand how it's distributed and what interventions can be applied, especially culturally specific interventions for each country and community, there's less research on this topic. So there is definitely an increased need for research in financial toxicity, particularly in the global setting. Dr. Hope Rugo: Yes, and I think that goes on to how we hope that financial toxicity researchers will have approaches to large-scale multi-institutional interventions to improve financial toxicity. I think this is an enormous challenge, but one of the SWOG organizations has done some great work in this area, and a randomized trial addressing cancer-related financial hardship through the delivery of a proactive financial navigation intervention is one area that SWOG has focused on, which I think is really interesting. Of course, that's going to be US-based, which is how we might find our best paths starting. Do you think that's a good path forward, maybe that being able to provide something like that across institutions that are independent of being a cancer only academic center, or more general academic center, or a community practice? You know, is finding ways to help patients with breast cancer and their families understand and better manage financial aspects of cancer care on a national basis the next approach? Dr. Kamaria Lee: Yes, I agree that that is a good approach, and I think the proactive component is also key. We know that patients that are coming to us with any cancer, but including breast cancer, some of them have already experienced a financial burden or have recently had a job loss before even coming to us and having the added distress of our direct costs and our indirect costs. So I think being proactive when they come to us in regards to the additional burden that their cancer treatments may cause is key to try to get ahead of things as much as we can, knowing that even before they've seen us, there might be many financial concerns that they've been navigating.  I think at the national level, that allows us to try to understand things at what might be a higher level of evidence and make sure that we're able to address this for a diverse cohort of patients. I know that sometimes the enrollment can be challenging at the national level when looking at financial toxicity, as then we're involving many different types of financial navigation partners and programs, and so that can maybe make it more complex to understand the best approaches, but I think that it can be done and can really bring our understanding of important financial toxicity interventions to the next level. And then the benefit to families with the proactive component is just allowing them to feel more informed, which can help decrease anticipation, anxiety related to anticipation, and allow them to help plan things moving forward for themselves and for the whole family. Dr. Hope Rugo: Those are really good points and I wonder, I was just thinking as you were talking, that having some kind of a process where you could attach to the electronic health record, you could click on the financial toxicity survey questions that somebody filled out, and then there would be a drop-down menu for interventions or connecting you to people within your clinic or even more broadly that would be potential approaches to manage that toxicity issue so that it doesn't impact care, you know, that people aren't going to decide not to take their medication or not to come in or not to get their labs because of the cost or the transportation or the home care issues that often are a big problem, even parking, as you pointed out, at the cancer center. And actually, we had a philanthropic donor when I was at UCSF who donated a large sum of money for patient assistance, and it was interesting to then have these sequential meetings with all the stakeholders to try and decide how you would use that money. You need a big program, you need to have a way of assessing the things you can intervene with, which is really tough. In that general vein, you know, what are the governmental, institutional, and provider-level actions that are required to help clinicians do our best to do no financial harm, given the fact that we're prescribing really expensive drugs that require a lot of visits when caring for our patients with breast cancer in the curative and in the metastatic setting? Dr. Kamaria Lee: At the governmental level, there are patient assistant programs that do exist, and I think that those can continue and can become more robust. But I also think one element of those is oftentimes the programs that we have at the government level or even institutional levels might have a lot of paperwork or be harder for people with lower literacy levels to complete. And so I think the government can really try to make sure that the paperwork that is given, within reason, with all the information they need, but that the paperwork can be minimized and that there can be clear instructions, as well as increased health insurance options and, you know, medical debt forgiveness as more broad just overall interventions that are needed. I think additionally, institutions that have clinical trials can help ensure that enrollment can be at geographically diverse locations. Some trials do reimburse for travel costs, of course, but sometimes then patients need the reimbursement sooner than it comes. And so I think there's also those considerations of more so upfront funds for patients involved in clinical trials if they're going to have to travel far to be enrolled in that type of care or trying to, again, make clinical trials more available at diverse locations.  I would also say that it's important that those who design clinical trials use what is known as the “Common Sense Oncology” approach of making sure that they're designed in minimizing the use of outcomes that might have a smaller clinical benefit but may have a high financial toxicity. And that also goes to what providers can do, of understanding what's most important to a particular patient in front of them, what outcomes and what benefit, or you know, how many additional months of progression-free survival or things like that might be important to a particular patient and then also educating them and discussing what the associated financial burden is just so that they have the full picture as they make an informed decision. Dr. Hope Rugo: As much as we know. I mean, I think that that's one of the big challenges is that as we prescribe these expensive drugs and often require multiple visits, even, you know, really outside of the clinical trial setting, trying to balance the benefit versus the financial toxicity can be a huge challenge. And that's a big area, I think, that we still need help with, you know. As we have more drugs approved in the early-stage setting and treatments that could be expensive, oral medications, for example, in our Medicare population where the share of cost may be substantial upfront, you know, with an upfront cost, how do we balance the benefits versus the risk? And I think you make an important point that discussing this individually with patients after we found out what the cost is. I think warning patients about the potential for large out-of-pocket cost and asking them to contact us when they know is one way around this. You know, patients feeling like they're sort of out there with a prescription, a recommendation from their doctor, they're scared of their cancer, and they have this huge share of cost that we didn't know about. That's one challenge, and I don't know if there's any suggestions you have about how one should approach that communication with the patient. Dr. Kamaria Lee: Yes, I think part of it is truly looking at each patient as an individual and asking how much they want to know, right? So we all know that patients, some who want more information, some want less, and so I think one way to approach that is asking them about how much information do they want to know, what is most helpful to them. And then also, knowing that if you're in a well-resourced setting that does have the social workers and financial navigators, also making sure it's integrated in the multidisciplinary setting and so that they know who they can go to for what, but also know that as a clinician, you're always happy for them to bring up their concerns and that if it's something that you're not aware of, that you will connect them to the correct multidisciplinary team members who can accurately provide that additional information. Dr. Hope Rugo: Do you have any other additional comments that you'd like to mention that we haven't covered? I think the idea of a financial toxicity screen with two questions that could be implemented at change of therapy or just periodically throughout the course of treatment would be a really great thing, but I think we do need as much information on potential interventions as possible because that's really what challenges people. It's like finding out information that you can't handle. Your article provides a lot of strategies there, which I think are great and can be discussed on a practice and institutional level and applied. Dr. Kamaria Lee: Yeah, I would just like to thank you for the opportunity to discuss such an important topic within oncology and specifically for our patients with breast cancer. I agree that it can feel overwhelming, both for clinicians and patients, to navigate this topic that many of us are not as familiar with, but I would just say that the area of financial toxicity is continuing to evolve as we gather more information on most successful interventions and that our patients can often inform us on, you know, what interventions are most needed as we see them. And so you can have your thinking about it as you see individual patients of, "This person mentioned this could be more useful to them." And so I think also learning from our patients in this space that can seem overwhelming and that maybe we weren't all trained on in medical school to best understand how to approach it and how to give our patients the best care, not just medically, but also financially. Dr. Hope Rugo: Thank you, Dr. Lee, for sharing your insights with us today. Our listeners will find a link, as I mentioned earlier, to the Ed Book article we discussed today in the transcript of this episode. I think it's very useful, a useful resource, and not just for providers, but for clinic staff overall. I think this can be of great value and help open the discussion as well. Dr. Kamaria Lee: Thank you so much, Dr. Rugo. Dr. Hope Rugo: And thanks to our listeners for joining us today. Please join us again next month on By the Book for more insightful views on topics you'll be hearing at Education Sessions from ASCO meetings and our deep dives into new approaches that are shaping modern oncology. Thank you. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:       Dr. Hope Rugo  @hope.rugo  Dr. Kamaria Lee @ lee_kamaria Follow ASCO on social media:       @ASCO on X (formerly Twitter)       ASCO on Bluesky      ASCO on Facebook       ASCO on LinkedIn       Disclosures:      Dr. Hope Rugo:   Honoraria: Mylan/Viatris, Chugai Pharma  Consulting/Advisory Role: Napo Pharmaceuticals, Sanofi, Bristol Myer  Research Funding (Inst.): OBI Pharma, Pfizer, Novartis, Lilly, Merck, Daiichi Sankyo, AstraZeneca, Gilead Sciences, Hoffman La-Roche AG/Genentech, In., Stemline Therapeutics, Ambryx    Dr. Kamaria Lee: No relationships to disclose  

TWiV discusses the latest worrisome Executive Order on oversight of federal grantmaking, RFK Jr winds down mRNA viral vaccine development, Lenacapavir, a drug for AIDS prevention and treatment, and how respiratory virus infections awaken dormant metastatic breast cancer cells in lungs. Hosts: Vincent Racaniello, Alan Dove, Rich Condit and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Oversight of Federal grantmaking (Whitehouse.gov) Grantmaking gets a Christofascist (Rasmussen Retorts) HHS winds down mRNA vaccine development (HHS) Lives saved by COVID vaccines (JAMA) Lenacapavir review (Bicochem Pharm) UNAIDS urges Gilead to lower price of lenacapavir (UNAIDS) Gilead and price gouging (Wikipedia) Respiratory virus infections awaken metastatic breast cancer (Nature) Letters read on TWiV 1243 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Brianne – Xkcd: Geologic Periods Rich – Old Man's War by John Scalzi Alan – The Broken Earth trilogy by N. K. Jemisin Vincent – Cacio e pepe: Good Food pasta recipe sparks fury in Italy Listener Pick Linda – DNA captured in air could identify life forms Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

The co-creator of Absolutely Fabulous says her remarkable career as one of the world's funniest women is all down to a series of happy accidents. When she and her great pal Dawn French were making their first series, French & Saunders, they were given complete freedom by the BBC, including the freedom to fail.Despite a few mishaps along the way and a battle with breast cancer, Jennifer now says that early freedom, risk-taking and random opportunities were the best things that could possibly have happened to them.Further informationFirst broadcast in April, 2014.You can hear Sarah's full conversation with Timothy Spall on the ABC Listen App, or wherever you get your podcasts.You can also read all about the Conversations origin story on the ABC News website.This episode of Conversations explores memoir, books, writing, TV comedy, Ab Fab, celebrity memoir, battling cancer, survival stories, breast cancer, British humour, dark humour, Black Books, the Comic Strip, Friends, Roseanne, Adrian Edmondson,  Edina Monsoon, Joanna Lumley, Patsy Stone, Muppets, Spice Girls, Top Gear.

Fresh off a silver medal in Singapore at the World Aquatic Championships, where she didn't realise she was part of a dead heat, Jenna Forrester is proud of what she's got through to find success. Joining Declan Byrne on ‘The Saturday Sledge' Forresters talks about overcoming a shift in her identity, dealing with heightened expectations and sickness to her hero her Mum and what life is like under coach Dean Boxall alongside Ariarne Titmus, Mollie O'Callaghan and more.

In this heartfelt episode, I share a story of one of my clients who chose to live as if she was cured—even while waiting for a PET scan. Her courage and clarity inspired this conversation about mindset, belief, and the science behind choosing peace in uncertain moments.   We'll explore: The difference between what's true and what fear tells us The emotional and biological cost of staying in survival mode Studies that show how belief and agency improve healing outcomes How to anchor into peace with simple daily practices Why the story you tell yourself is powerful medicine Plus, I'll leave you with a reflective journal prompt to help you shift your mindset the next time fear creeps in. This is a must-listen for breast cancer survivors and anyone learning to live in the space between healing and uncertainty.   Mentioned Studies: Leedham et al., 1995 – Health Psychology Taylor & Armor, 1996 – Journal of Personality Hack et al., 2005 – Patient Education and Counseling   Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

Nutritionist Leyla Muedin reveals the alarming increase in obesity-associated cancers in the United States over the past two decades. Highlighting findings from a recent study presented at the Endocrine Society's annual meeting, Leyla underscores the significant rise in cancer deaths linked to obesity, particularly among women, older adults, Native Americans, and Black Americans. She also explores the complex causes of obesity, including genetics, lifestyle, and environmental factors, and offers insights into effective weight management strategies. Additionally, Leyla examines the high rates of heart disease in various U.S. states, emphasizing the importance of lifestyle modifications and public health initiatives to combat cardiovascular diseases.

"Ripped From The Headlines" is a new series for Breaking the Code, where Sonika and Gabe react to a news story with a medical anthropology lens. On this edition, they react to Anixa Biosciences' breast cancer vaccine completing phase one of clinical testing. The notion of a cancer vaccine sparked a variety of conversation topics from women's health to vaccine culture. If you love to listen to rich, fast-evolving conversations, then give this a listen and let us know what you think!Follow us on LinkedIn

At the start of her second trimester, Rafaela Dreisin was diagnosed with breast cancer at the age of 36. Listen to the episode to hear Rafaela discuss: how she and her doctors decided on a treatment plan how she coped with experiencing the excitement of being pregnant and the fear of her diagnosis at the same time her advice for other people in the same situation

Checking in after 2 years since I was diagnosed with invasive breast cancer to share that recovery from the trauma of a diagnosis is possible.  In the last episode I talked about inner strength that I use in managing my mindset as a survivor. The outlook of knowing I will be ok and controlling the things I am allowed to control does not restrict me from looking back at my recovery. This podcast is about sharing my story and advocating. The milestones of recovery from what makes up a diagnosis are important to reflect on, in my opinion.  Since it is summer, I am going to my pool fairly often right now. I love how the water feels on my body and swimming has always been a therapeutic activity for me. So of course I went to my pool as soon as I could after my surgery (2 years ago).  As I work to set goals in my life (also something I talked about in the last episode), I am planning more fun activities each week. Last week I met up at the pool with a few friends and neighbors. This pool time (alone or with friends) is what I call a “great escape”. It is not really an adventure but it takes me to such a different place the moment I enter the gates of the pool.   I crave these moments away from all that makes up my life. In the pool (at the pool), it is a time to move in the water and release physical and emotional tension as I swim (usually very leisurely) up and down the lanes. Last week, when I was with my friends, we sat and ate chips and dip (definitely therapeutic) before going to kick and talk in the water. We had a lot of space to ourselves and it was a completely relaxing block of time.  So as in last week's episode I talked about doing more than just going through the motions of each week in a month, year, etc., I share my experience of how this can be such a boost to keeping connected and having a positive outlook plus some fun during a day in my breast cancer life.  I cannot say for sure if I would have found it so important to block out fun and intentionally plan my life ahead (for fun and function) if I had not been diagnosed with breast cancer. I do know that because of my breast cancer experience, I am grasping on to opportunities to have fun and connect with others, while also taking care of me with great intention.   My recent episode about navigating the mindset in survivorship:  Episode 57 Inner Strength Unveiled: Navigating Mindset and Hope After Breast Cancer If you are interested in hearing my episode about the healing effects of swimming for me, listen here: Episode 48 Swimming for Self Love as a Breast Cancer Survivor Also, if you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list! LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest 

Anticipating and managing CDK4/6 inhibitor toxicities in HR+ HER2- breast cancer is essential to improving patient quality of life and optimizing clinical outcomes. In this episode, CANCER BUZZ speaks with Diana Van Ostran, PharmD, BCOP, clinical pharmacy specialist – breast clinic at Miami Cancer Institute, Baptist Health South Florida, about strategies to monitor and manage treatment-related adverse events in patients with early-stage and metastatic breast cancer receiving CDK4/6 inhibitors. She discusses the importance of individualized care and robust patient education around lifestyle and dietary techniques to improve tolerance of this treatment.   Diana Van Ostran, PharmD, BCOP  Clinical Pharmacy Specialist – Breast Clinic Miami Cancer Institute Baptist Health South Florida  Miami, FL   “Clinical pharmacists play a vital role in managing the patient's treatment. Because, as we know, if you're having excessive side effects, patients are going to be less likely to take their medications.”   Resources: ACCC Adverse Event Management for CDK Inhibitors in HR+ Breast Cancer ACCC CDK Inhibitors Management Miami Cancer Institute ACCC Spotlight on Miami Cancer Institute: The Role of a Breast Cancer Clinical Pharmacy Specialist for CDK4/6 Inhibitor Management

What happens when you’re diagnosed with breast cancer at 42, while running a business, raising a family, and just married? Today, Dorothy talks with Gaylyn, a longtime Rose patient and community volunteer, who found a lump in her breast, advocated for herself, and learned what it means to lean on others. Key insights from this episode: How early detection shaped her journey What it means to accept help Finding strength through connection with others Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. How did Gaylyn first connect with The Rose? 2. How did Gaylyn’s breast cancer diagnosis process unfold? 3. How did having previous medical records help her diagnosis? 4. How did Gaylyn advocate for herself during her diagnosis and treatment? 5. What treatment did she undergo for breast cancer? 6. What role did her husband play during her treatment? 7. What are some emotional and practical challenges Gaylyn faced during treatment? 8. What advice does Gaylyn share for women going through breast cancer or similar experiences? 9. How does Gaylyn feel about sharing her experience and helping others? 10. What lessons did she learn about saying ‘no’ and setting boundaries during her battle with cancer? 11. How did her faith and community support impact her journey? Timestamped Overview 00:00 Early Mammogram Advocacy Success 06:00 Rapid Surgery Decision 07:34 Skipping Chemo for Early Stage 12:37 They Can't Fix It 15:19 Grant Yourself Grace 16:14 Self-Care Through Adversity Lessons 20:50 Scars as Milestones of Healing 25:10 Entrepreneurial Challenges Amid Illness 26:12 Embrace Support Graciously 32:11 Embrace Vulnerability 33:08 Embrace Authentic Emotions OpenlySee omnystudio.com/listener for privacy information.

(00:00:00) Life's Lessons From a Mother's Fight (00:00:00) Life's Lessons From a Mother's Fight (00:00:00) Life's Lesson's From a Mother's Fight (00:06:20) Andy's Journey Through Multiple Traumas (00:12:10) Finding Freedom in Letting Go of Control (00:12:10) Finding Freedom in Letting Go of Control (00:16:39) How Core Beliefs Shape Resilience (00:22:50) Building Your Default Network for Crisis (00:27:47) Transforming Pain Into Purpose How do you keep going when everything has been taken from you? Andy Campbell's story will stop you in your tracks.After surviving childhood sexual abuse, losing his mother to cancer, battling stage 4 pancreatic cancer (which he has now survived for nearly seven years against all odds), and enduring the devastating loss of his son to suicide, Andy has earned the right to speak about resilience in a way few others can.The most profound moment in our conversation comes when Andy describes his cancer diagnosis. Having watched his mother and three aunts die from cancer, he had spent years preparing for what he thought would be inevitable, only to be blindsided by pancreatic cancer instead. In that moment of complete helplessness, Andy discovered something unexpected: freedom. "The recognition that I had no control over it was probably the most freeing moment in my life," he shares.What sets this conversation apart is Andy's practical approach to resilience. He describes developing "core beliefs" that function like a computer's BIOS - fundamental operating instructions that kick in when all else fails. These beliefs, which he's compiled in his book "Overcoming Life's Toughest Setbacks," serve as a default network during times when clear thinking is impossible.Perhaps most moving is Andy's reason for sharing his story. Not to showcase his strength, but to reach someone who might be contemplating giving up. "I have been broken, I have been beaten, I have been down on my knees. Honest to God, some days I don't know how I'm still here, but if I can do it, you can do it."Visit askandycampbell.com to learn more about Andy's journey and his approach to transforming life's greatest challenges into opportunities for growth and connection.Become a supporter of this podcast: https://www.spreaker.com/podcast/bereaved-but-still-me--2108929/support.

The unexpected sight of blood when you're eight years post-menopause can trigger immediate alarm bells. That's exactly what happened to me in September 2024, launching me on a journey that ultimately led to having a hysterectomy at age 55.This very personal episode takes you through my complete hysterectomy experience – from the shocking discovery of post-menopausal bleeding to my recovery two weeks after robotic laparoscopic surgery. I share the medical investigations that revealed my significantly thickened uterine lining (likely caused by previous Tamoxifen treatment for Breast Cancer), the decision-making process that led to surgery, and exactly what happened during my hospital stay.You'll hear all the details about my physical recovery and my gradual return to movement and normal activities. I discuss my frustrations with vague post-surgery exercise guidelines and how I advocated for more personalised recovery information as someone who regularly engages in heavy resistance training.Throughout this episode, I emphasise that while I'm sharing my story to help others, everyone's hysterectomy journey is unique. Your body, your choices, and your recovery will follow their own path. I've included practical tips about freezing meals before surgery, focusing on healing nutrition, and the importance of gentle movement in recovery.This is the first in what will be a five-part series documenting my hysterectomy journey, with future episodes at weeks 4, 6, 9 and 12 post-surgery.If you're facing a hysterectomy, supporting someone who is, or simply curious about what this experience entails, I hope my candid sharing provides insight, reassurance, and perhaps some practical guidance for your journey.You can send me any questions or share your story with me on my Instagram @sonyalovell or email sonya@sonyalovell.comResources:Sonya Lovell on InstagramTamoxifen and Uterine Lining ACOG paperJournal of Obstetrics and Gynaecology paperThank you for listening to my show! Join the conversation on Instagram

REPLAY FROM 11/13: In this episode, we sit down with Dr. Stacy Barczak Baker and dive into the often overlooked connections between hormones, insulin, and environmental factors like lighting and food. We discuss how everyday habits—like staring at screens, exposure to blue and artificial light, even the chemicals we use in our daily routines—and how they are silently contributing to chronic stress and hormone issues. Dr. Stacy shares simple lifestyle changes—such as getting sunlight early in the day, wearing yellow glasses, or using incandescent bulbs—and how these habits can drastically help reset your body's internal clock and support healthy hormone levels. We also discuss the increasing diagnosis of breast cancer and how we can adjust certain lifestyle habits to reduce our risk of certain types of breast cancer.Episode Topics:Why balancing insulin and hormones is critical for your healthThe shocking effects of blue and artificial light on your cortisol levelsSimple, effective tips for protecting your hormones from environmental stressorsHow food, light, and chemicals interact with your body in ways you may not expectDaily practices to improve hormonal balancingBreast cancer awareness: How to address hormonal imbalances to avoid cancer diagnosisHow we can be empowered when it comes to understanding how to prevent certain cancers, like breast cancermuch much more!Follow Dr. Stacy on InstagramDr. Stacy's WebsiteLINK to Dr. Stacy's episode on Breast Cancer

To have your question featured in a future video, please email: questions@morses.tv Please include at least: Age, Weight and as much history as possible.

In this episode, host Talaya Dendy sits down with Katharine Giovanni, an award-winning author, speaker, and transformation mentor. As a stage three breast cancer survivor, Katharine knows firsthand that everyone tells you to forgive, but no one teaches you how. Katharine shares her journey of survival and demystifies the practice of forgiveness. The conversation explores how to navigate difficult emotions, enhance quality of life, and find peace after a life-altering event like cancer. Listeners will learn how forgiveness can be a powerful tool for healing, self-compassion, and emotional resolution, not just for cancer survivors, but for anyone facing life's toughest challenges.

Embracing Change: From Breast Cancer to Being Nice to YourselfIn this episode of The Girl Doc Survival Guide, Christine edited an episode from the Lean Out Podcast with Dr. Dawn Baker. The conversation covers Christine's journey with a breast cancer diagnosis and its impact on her work. They discuss the importance of self-care, the fixed mindset, and having hobbies. Christine shares insights from her journey as a parent of a young patient and her reflections on medical decisions, emphasizing the value of patient education and listening to one's intuition.00:00 Introduction and Podcast Overview00:31 Unexpected Directions in the Interview00:58 Balancing Work and Life Post-Cancer Diagnosis02:37 Exploring New Hobbies and Interests03:02 Writing and Parenting Influences03:34 Navigating Medical Challenges with a Child07:19 Reflections on Parenting Decisions09:11 Fixed Mindset and Personal Growth11:41 Being Kinder to Yourself13:26 Conclusion and Podcast Outro

Stephanie is a young breast cancer survivor and the daughter of a breast cancer survivor. She is also a Certified Cannabis Educator and Patient Care Coach with True Roots Healthcare in Ontario, Canada where she helps women who are struggling with Breast Cancer side effects including anxiety, sleep, pain and more. In 2020 Stephanie co-founded the non-profit organization, EduCanNation, a diverse group of Certified Cannabis Educators who are raising the level and standards of Cannabis Education in Canada, the United States and internationally. Stephanie is also the Co-Host of A Tincture of Time Podcast, which focuses on cannabis education, specifically a dive into the science and evidence that support cannabis as medicine.

In this episode of Onc Now, host Jonathan Sackier is joined by Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford, UK, to discuss translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Lord brings a unique perspective on how the future of cancer therapy is being shaped today.      Timestamps  01:04 – Quickfire question  11:26 – Metabolic imaging  15:26 – Insulin resistance  18:04 – Patient-specific biology  20:35 – Tamoxifen risks  21:57 – Metabolic interventions  24:46 – Lifestyle changes  27:04 – Clinical trials  00:00 – Wishes for healthcare 

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Neil M. Iyengar, MD Guest: Komal Jhaveri, MD, FACP The second-line treatment of HR+/HER2-advanced breast cancer has evolved in recent years, particularly with the rise of biomarker-driven strategies targeting PI3Kα and other mutations. But given these advances, there's a lot we need to think about when selecting therapy, like the differences between selective and non-selective inhibitors, toxicity profiles, and shared decision-making. Joining Dr. Charles Turck to share their insights on those key considerations and how we can personalize care for patients with PI3Kα-mutated HR+/HER2- advanced breast cancer are Drs. Komal Jhaveri and Neil Iyengar. Dr. Jhaveri is the section head for the Endocrine Therapy Research Program in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center, and Dr. Iyengar is the Co-Director of the Breast Oncology Program at the Winship Cancer Institute at Emory University.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Neil M. Iyengar, MD Due to their wild-type inhibition, first-generation PIK3CA inhibitors for HR+/HER2- advanced breast cancer were limited by significant toxicities, including hyperglycemia, rash, and diarrhea. But now, mutation-specific PIK3CA inhibitors could help improve tolerability and adherence as well as simplify dosing strategies—all while maintaining efficacy. To learn more about the efficacy and safety of current and emerging PIK3CA-targeted therapies, Dr. Charles Turck speaks with Dr. Neil Iyengar, Co-Director of the Breast Oncology Program and Director of Cancer Survivorship Service at Winship Cancer Institute at Emory University.

Watch hol+ by Dr. Taz MD on YouTube: https://www.youtube.com/@DrTazMD/podcastsThe incidence of breast cancer is rising and has now surpassed lung cancer as the leading cancer worldwide. This script features a comprehensive discussion between the host and Dr. Kristi Funk, a double board-certified breast cancer surgeon and lifestyle medicine doctor. The conversation covers the rising rates of breast cancer, key risk factors such as diet, exercise, and lifestyle choices, and the role of early detection and screening. Dr. Funk shares her personal experiences, insights on how younger and older women can reduce their risk, the impact of hormone replacement therapy, and the importance of lifestyle modifications. Additionally, advancements in breast cancer treatments, including immunotherapy and personalized medicine, are explored as hopeful developments in the fight against breast cancer.About Dr. Kristi FunkKristi Funk, M.D. is a double board-certified breast cancer surgeon, and lifestyle medicine doctor, bestselling author, and international speaker. She graduated from Stanford University in 1991, received her medical degree from UC Davis, completed her surgical residency in Seattle, and a breast cancer fellowship at Cedars-Sinai in Los Angeles. She excelled as a Director of the Cedars-Sinai Breast Center until 2009 when Dr. Funk co-founded the the Pink Lotus Breast Center in Los Angeles where she currently practices. She has helped thousands of women navigate breast issues, including celebrities like Angelina Jolie and Sheryl Crow. Dr. Funk's nutritional science expertise sparked twin passions: the online women's social network, Pink Lotus Power Up, and her annual in-person or virtual Cancer-Kicking! Summits. She is the go-to breast expert for Good Morning America and Dr. Phil's Merit Street Media; she was a co-host of The Doctors tv show, and has repeatedly appeared on Today, Rachael Ray, The Dr. Oz Show, CNN, The View, and more. She resides in Los Angeles, CA, with her husband and triplet sons.Stay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Kristi Funk:https://www.instagram.com/drkristifunkhttps://pinklotus.com/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+Time Stamps02:53 Current Trends and Statistics in Breast Cancer06:27 The Role of Genetics and Lifestyle in Breast Cancer09:33 Diet, Exercise, and Environmental Factors35:06 The Impact of Emotional Health on Breast Cancer41:22 Breast Cancer Screening for Young Women47:47 The Debate on Mammograms and Ultrasounds50:39 Understanding DCIS: Overdiagnosis and Overtreatment58:41 Hormone Replacement Therapy and Breast Cancer01:13:41 Future of Breast Cancer Care and Treatment

You may have heard in the news that younger women are being diagnosed with breast cancer at higher rates than before. While women under 40 only account for 4% of breast cancer cases in the U.S., even a modest rise in breast cancer incidence is a call to action for young women to understand their personal risk and to know what's normal for their breasts so they can be aware of any changes that should be reported to a health care provider. Joining us on the show today is Dr. Virginia Borges, a medical oncologist at the University of Colorado, whose research focuses on young women's breast cancer. Dr. Borges is committed to finding answers and today will share what is being studied, as well as how young women can be empowered to take charge of their breast health early.

In this powerful episode of Keeping Abreast, Dr. Jenn sits down with Warren Phillips—also known as the Non-Toxic Dad—for a raw and revealing look at the hidden toxic exposures affecting our everyday lives.Together, they explore the deep connection between environmental toxins and chronic illness, the dark truth behind greenwashing, and why detoxification may be even more important than nutrition when it comes to long-term health. Warren shares his personal journey from industrial toxicity to healing, and unpacks why women are uniquely positioned to lead the movement toward a cleaner, safer future.From the hormone-disrupting effects of receipts and fragrance to the overlooked link between alcohol and breast cancer, this episode is a wake-up call for anyone who wants to reclaim their health—starting at home. If you've ever questioned the safety of your skincare, cookware, or even your clothing, this conversation will leave you informed, empowered, and ready to make changes that last.In This Episode, You Will Learn:Why detoxification may matter more than nutritionHow greenwashing keeps harmful products on store shelvesThe shocking truth about fragrance and hormone disruptionHow microplastics are invading our bodies—and what to do about itWhy alcohol is a leading, modifiable risk factor for breast cancerWhat makes women powerful changemakers in household healthSimple swaps that reduce toxin exposure in your kitchen and bedroomHow cookware, cutting boards, and containers can affect your hormonesWhy conventional hormone replacement can be risky—and how to do it safelyHow a non-toxic lifestyle supports longevity, energy, and mental clarity

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data and shares clinical investigator perspectives on the role of TROP2-directed antibody-drug conjugates in the management of HR-positive and triple-negative breast cancers. CME information and select publications here.

Featuring an interview with Dr Erika Hamilton, including the following topics: Optimal selection and sequencing of available antibody-drug conjugates for HR-positive metastatic breast cancer (0:00) Bardia A et al. Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer: Primary results from TROPION-Breast01. J Clin Oncol 2025;43(3):285-96. Abstract  Pistilli B et al. Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative breast cancer: Final overall survival from the Phase III TROPION-Breast01 trial. ESMO Virtual Plenary 2025;Abstract VP1-2025. First-line use of sacituzumab govitecan in combination with pembrolizumab for advanced triple-negative breast cancer (8:02) Tolaney SM et al. Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study. ASCO 2025;Abstract LBA109. Ongoing trials evaluating datopotamab deruxtecan in earlier lines of therapy (12:06) Dent RA et al. TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer. Future Oncol 2023;19(35):2349-59. Abstract McArthur HL et al. TROPION-Breast04: A randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2- breast cancer. Ther Adv Med Oncol 2025;17:17588359251316176. Abstract Bardia A et al. TROPION-Breast03: A randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy. Ther Adv Med Oncol 2024;16:17588359241248336. Abstract Schmid P et al. TROPION-Breast05: A randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer. Ther Adv Med Oncol 2025;17:17588359251327992. Abstract Available data with and ongoing trials of sacituzumab tirumotecan for HR-positive, HER2-negative and triple-negative breast cancer (16:53) Yin Y et al. Sacituzumab tirumotecan (sac-TMT) as first-line treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from the phase II OptiTROP-Breast05 study. ASCO 2025;Abstract 1019. Xu B et al. Sacituzumab tirumotecan in patients with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the Phase III Opti-TROP-Breast01 study. ASCO 2024;Abstract 104. Yin Y et al. Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: A randomized phase 3 trial. Nat Med 2025;31(6):1969-1975. Abstract Garrido-Castro AC et al. SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic HR+/HER2-negative breast cancer. ASCO 2024;Abstract LBA1004. CME information and select publications

Meet Shana Alayev, a wife, mother of four, and speech therapist who is facing stage four cancer with brutal honesty, raw humor, and unshakable emunah. In this emotional and deeply human conversation, Shana opens up about her journey: from a delayed diagnosis during pregnancy to navigating treatment, parenting through pain, and redefining faith, purpose, and resilience every single day. Her story isn't just about illness, it's about choosing hope when the path is unclear, and finding light in the darkest places. WonderWomen is a community dedicated to empowering and supporting young Orthodox Jewish women diagnosed with breast cancer. www.weareww.org      

Can you keep eating dairy or sourdough bread during breast cancer recovery—or do they need to go? In this episode, I walk you through the confusing world of food myths and metabolic health, exploring: The difference between A1 and A2 dairy What the research says about dairy and cancer risk Whether sourdough bread is truly blood sugar–friendly How gluten impacts gut health (and what zonulin has to do with it) And the truth behind the “toast your bread to reduce carbs” trend   Whether you love yogurt or can't part with crusty sourdough, you'll leave this episode with clarity—not guilt.

This is a bonus episode of the audio of a Breastcancer.org webinar. It's normal to experience emotional challenges after a cancer diagnosis. From body image to managing relationships, heightened stress, the fear of recurrence, and so much more.  In this webinar, you'll learn about a variety of ways to cope with the anxiety and doubts that can take hold.  Breast cancer patients and survivors will share what helps them manage their mental health struggles. They discuss candidly how they find strength and hope even on their most difficult days.   We'll also hear from experts on finding mental health support and different approaches to getting the help you need.  After you watch the webinar, hear Dr. Stephanie Ross answer more audience questions in a “Stage Free” podcast interview. And learn more about taking care of your mental health after a breast cancer diagnosis. Featured Speakers: Martha Gamez-SmithBreast Cancer Advocate Loriana Hernández-AldamaFounder, ArmorUp for LIFE Allison KoMetastatic Breast Cancer Advocate Stephanie Ross, PhDFounder, Illness Navigation Resources Carolyn TeschlerBreast Cancer Advocate Tiah Tomlin-HarrisBreast Cancer Advocate, Breastcancer.org Virtual Support Group facilitator Marisa Weiss, MDChief Medical Officer, Breastcancer.org

Sophie Blake, who lives with secondary breast cancer, talks to Laura about Breast Cancer Now's campaign to make sure everyone with breast cancer across the UK can get access to the drugs they need to survive. Eleanor from Breast Cancer Now also joins the conversation to explain the issues with the drug approval system in England, Wales and Northern Ireland, and what work Breast Cancer Now is doing to help change things. Help us take action now with our automatic form that contacts your MP asking them to help fix the system. Find out more about Breast Cancer Now's campaign, #MoreTimeToLive You can follow Sophie Blake on X @sophieRblake and Instagram @sophieblake72. If you'd like to find out more about Breast Cancer Now's support services, visit the Breast Cancer Now website or phone our free helpline on 0808 800 6000 (UK only). You can subscribe to this podcast on Spotify, Apple Podcasts, or wherever you get your podcasts. Every episode is available to watch or listen to on the Breast Cancer Now website. You can also watch it on YouTube. Key Topics: 2:01 Sophie explains what secondary breast cancer means to her 3:23 The importance of access to breast cancer drugs 4:54 The meaning of "More Time To Live" 6:44 Enhertu: a drug that was rejected for use on the NHS in England 10:10 Eleanor outlines the problem with drugs not being approved 13:07 The Severity Modifier, explained 18:38 The reality that people are dying of breast cancer every day 22:23 Breast Cancer Now's recommendations to MPs to help change the system 25:49 The response to the campaign so far from Wes Streeting and NICE 28:21 The timescales required for change 34:33 How listeners can get involved in the More Time To Live campaign 37:31 Sophie talks about the impact of her campaigning on her family 42:39 What it means to Eleanor to live well 44:30 What it means to Sophie to live well

In this episode of, “Your Voice. Your Health”, we take a closer look at step therapy but this time through a financial lens. I sat down with Monica Bryant, Esq., Chief Mission Officer of Triage Cancer, to talk about how step therapy can create unexpected financial obstacles—from rising co-pays and delayed treatment to challenges with insurance coverage and staying employed during treatment in  your health plans, navigating appeals, and accessing financial aid. She also shares practical tips for choosing insurance plans, minimizing out-of-pocket costs, and using tools like Triage Cancer's new health insurance comparison calculator to make informed, cost-conscious decisions. If you or a loved one is facing treatment delays or financial stress related to step therapy, this episode offers clear, actionable guidance to help you take control. Special thanks to Amgen and Daiichi-Sankyo for making this episode possible.  

Today I'm joined by the brilliant Dr Alison Macbeth, one of the most incredible menopause doctors of our generation, who supports our cancer community. Alison has been instrumental in shaping some of the most important chapters in my new book, Navigating Menopause After Cancer — especially those on vaginal oestrogen and the many non-hormonal treatment options available to cancer survivors.But during the process of helping me with the book, Alison herself was diagnosed with breast cancer.We talk about what it's like to cross over — from being the doctor, to becoming the patient. We explore how her diagnosis shifted her perspective and what it's taught her.We also talk about the importance of friendship, support systems, and what really matters when you're on the receiving end of care.It's an honour to share this conversation with you — and I hope it reminds you, like it reminded me, that none of us are alone in this.Thank you for listening — and as always, please share this episode with someone who needs it.Episode Highlights:00:00 Intro04:34 Breast Cancer Screening Anxiety10:53 Women's Support Crucial in Struggles15:13 Emotional Struggles and Recovery Journey26:41 "Informed Consent Lacking for Women"28:47 Choosing Endocrine Treatment Wisely30:37 "Mental Struggles in Treatment"34:28 "Understanding Personal Impact Varieties"Order the book: https://www.amazon.co.uk/Navigating-Menopause-After-Cancer-comprehensive/dp/1068499907 Dr Alison Macbeth's Instagram: https://www.instagram.com/dr_alison_macbeth/?hl=enJoin Alison for the Kilt Walk 14th Sept: https://fundraiseformenopauseandcancer.raiselysite.com/edinburghkiltwalkConnect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

How can you be a full-time mom to your children while also facing breast cancer? Can you do both? Today's guests share how they navigated two demanding roles – mom and patient – at the same time. Young women face even greater challenges when diagnosed young with breast cancer, as many are also raising young kids. Jennie Smythe had a 2-year-old son and 7-year-old daughter when she was diagnosed, and Siana Bennett had a 1-year-old son and 4-year-old daughter when she was diagnosed. Both are joining me today to tell us their stories.

The dark personality traits that underlie online political engagement; Parents' use of topical hormone preparations may pose unusual risks to their babies; Alternative to beta blockers for high blood pressure; Does lecithin lower cholesterol? Caloric restriction may extend life—but at what cost? A high-fiber diet may mimic caloric restriction's longevity benefits; Can mammograms cause cancer? 

Back on The Rewrite...She's known for her humor and heart—but this time, Rachel Sobel (@whineandcheezits) is bringing something even deeper to The Rewrite.In this powerful conversation, Rachel opens up about her recent breast cancer diagnosis and the whirlwind 26 days between hearing the news and undergoing a double mastectomy.We talk about:How she told her young daughtersThe way her second (and final) husband truly showed upThe role humor played in surviving the hard daysThe community she's built—and what it means to be seen, heard, and heldThe messages that have resonated mostAnd what The Rewrite means to her now, after this life-altering chapterFollow Rachel: @whineandcheezits

Guerdy Abraira from Real Housewives of Miami on Bravo joins Kate to discuss her cancer recovery journey and this season of the show. Reality Life with Kate Casey What to Watch List: https://katecasey.substack.com Patreon: http://www.patreon.com/katecasey Twitter: https://twitter.com/katecasey Instagram: http://www.instagram.com/katecaseyca Tik Tok: https://www.tiktok.com/@itskatecasey?lang=en Facebook Group: https://www.facebook.com/groups/113157919338245 Amazon List: https://www.amazon.com/shop/katecasey Like it to Know It: https://www.shopltk.com/explore/katecaseySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"We really are having the best of times during the worst of times." I'm fresh off my third round of chemotherapy (round two was rough!), and am back on the couch recording with friends. This time for chemo, I was joined by my best friend (and former Dance Spirit colleague!) Michael Anne Bailey, and this is our recap from the day at the infusion center and the few days we spent together. We share our friendship origin story, gush about the things we love most about each other, and talk a lot about eyebrows. SPONSOR:  New Balance: Click here to get your hands on the just-released Rebel v5! Follow Ali: Instagram @aliontherun1 Join the Facebook group Support on Patreon Subscribe to the newsletter SUPPORT the Ali on the Run Show! If you're enjoying the show, please subscribe and leave a rating and review on Apple Podcasts. Spread the run love. And if you liked this episode, share it with your friends!

In this enlightening conversation, Dr. Paige Gutheil and Jen Delvaux explore a range of topics related to women's health, particularly focusing on issues surrounding breast cancer, menopause, hormone replacement therapy, and the impact of these factors on overall well-being. They discuss the safety and efficacy of vaginal estrogen, the complexities of hormone replacement therapy in relation to breast cancer, and the importance of digestive health post-menopause/cancer. The conversation also delves into joint pain management for cancer survivors, hair loss related to hormonal changes, and the emerging role of GLP-1 medications after breast cancer. Finally, they emphasize the significance of stress management and the need for women to prioritize their health and happiness. Connect with Dr. Paige here: https://www.drpaige.com AnaOno: Intimate where for breast cancer survivors Join The Cancer Community HERE Hormone Safe Cleaning Products: HERE Magnesium from Seeking Health Supplements  Third Party Tested Protein Powder Use HELLO10 for $10 off The BLUEPRINT from Results to Rising details HERE FREE Download of cancer fighting vegan recipes: HERE Connect with me on Instagram: https://www.instagram.com/jendelvaux/ EMAIL ME: coachjennyd@gmail.com FAVORITE TEA: Pique Tea:  https://www.piquetea.com/?rfsn=5818415.d1d969a&utm_source=affiliate

“A great thing about having cancer is people are so nice to you!” This is my attempt to catch you up on what life has looked like since Chemo Round 2. Buckle up! SPONSORS:  UCAN: Click here to get a FREE UCAN sample pack (you'll just pay the cost of shipping), and use code ALI for 20% off your entire UCAN order. Vuori: Click here for 20% off your first Vuori purchase. Follow Ali: Instagram @aliontherun1 Join the Facebook group Support on Patreon Subscribe to the newsletter SUPPORT the Ali on the Run Show! If you're enjoying the show, please subscribe and leave a rating and review on Apple Podcasts. Spread the run love. And if you liked this episode, share it with your friends!